Combination use of atomoxetine hydrochloride and olanzapine in the treatment of attention-deficit/hyperactivity disorder with comorbid disruptive behavior disorder in children and adolescents 10-18 years of age

Journal of Child and Adolescent Psychopharmacology

Volumn 23, Issue 6, 2013, Pages 415-418

  Holzer, Barry ^a   Lopes, Vasco ^b   Lehman, Robert ^c  

^a Center for Attention Deficit and Behavioral Disorders   (United States)

^b FORDHAM UNIVERSITY   (United States)

^c Pharmasite Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; OLANZAPINE;

ADOLESCENT; AGGRESSION; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; COMORBIDITY; DISRUPTIVE BEHAVIOR; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MODIFIED OVERT AGGRESSION SCALE; OPEN STUDY; RATING SCALE; SCHOOL CHILD; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT GAIN;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; AGGRESSION; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BENZODIAZEPINES; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PROPYLAMINES; TIME FACTORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 84882760097     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2013.0029     Document Type: Article

References (15)

1. Aman MG, Binder C, Turgay A: Risperidone effects in the presence/ absence of psychostimulant medication in children with ADHD, other disruptive behavior disorders, and subaverage IQ. J Child Adolesc Psychopharmacol 14:243-254, 2004
2. Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL: Doubleblind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 159:1337-1346, 2002
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994
4. Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeler PM, Williams DW, Moore RJ, Levine L, Atomoxetine ADHD/ ODD Study Group: Atomoxetine for the treatment of attentiondeficit/ hyperactivity disorder and oppositional defiant disorder. Pediatrics 121:314-320, 2008
5. Barkley RA, Murphy K, Fischer MF: ADHD in adults: What the science says. New York: Guilford Press; 2008
6. Barzman DH, Belbello MP, Adler CM, Stanford KE, Strakowski SM: The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s). J Child Adolesc Psychopharmacol 16:665-670, 2006
7. Biederman J, Faraone S, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A: Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150:1792-1798, 1993
8. Buitelaar JK, Van der Gaag J, Cohen-Kettenis P, Melman TM: A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 62:239-248, 2001
9. Connor DF, Barkley RA, Davis HT: A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr 39:15-25, 2000
10. Costello JE, Mustillo S, Erkanli A, Keeler G, Angold A: Prevelance and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 60:837-844, 2003
11. DuPaul GJ, Power TJ, Anastopoulos, Reid R: ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation. New York: Guilford Press; 1998
12. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, Abikoff HB, Elliott G, Hechtman L, Hoza B, March JS, Newcorn JH, Severe JB, Vitiello B, Wells K, Wigal T: Findings from the NIMH multimodal treatment study of ADHD (MTA): Implications and applications for primary care providers. J Dev Behav Pediatr 22:60-73, 2001
13. Masi G, Milone A, Canepa G, Millepiedi S, Mucci M, Muratori F: Olanzapine treatment in adolescents with severe conduct disorder. Eur Psychiatry 21:51-57, 2006
14. Stephens RJ, Bassel C, Sandor P: Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome-A pilot study. J Child Adolesc Psychopharmacol 14:255-266, 2004
15. Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D: Overt aggression scale for the objective rating of verbal and physical aggression. Am J Psychiatry 143:35-39, 1986